Hong Kong Biotechnology company Adistem has unveiled a new study at a medical conference in France that shows promise in helping Type II diabetics through the use of the patient's own fat stem cells. Bangkok, Thailand (Netsweets) November 13,2008 -- Adistem, working with Dr. Bill Paspaliaris, conducted a nine-month study involving 37 diabetics and developed a medical method to activate dormant stem cells stored in body fat.

Adistem's technology separates fat stem cells from a patient's own fat, moves it into a test tube, then adds an activator solution. The activated cells are then given back to the patient and they begin to repair the body.

Paspaliaris presented the study in Toulouse, France at the IFATS Conference; a group of researchers working on fat stem cell technology and medical applications. More than 1,500 papers were submitted and Paspaliaris' study was one of only 15 chosen for presentation.

Click Here for Complete Article